Caption Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-910
Closed -$226K 1732
2025
Q4
$226K Hold
910
﹤0.01% 1363
2025
Q3
$191K Hold
910
﹤0.01% 1479
2025
Q2
$89.5K Buy
+910
New +$79.4K ﹤0.01% 1321
2021
Q1
Sell
-375
Closed -$290K 1202
2020
Q4
$290K Buy
375
+125
+50% +$98.5K 0.01% 805
2020
Q3
$247K Buy
+250
New +$265K 0.01% 889
2020
Q2
Sell
-750
Closed -$610K 1036
2020
Q1
$610K Buy
750
+375
+100% +$392K 0.03% 507
2019
Q4
$469K Sell
375
-163
-30% -$263K 0.02% 636
2019
Q3
$722K Buy
+538
New +$856K 0.04% 433

Other funds holding GOSS

Caption Management's GOSS Position: Q2 2026 in Review

Caption Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 891 shares — an estimated $23.4K sold.

Caption Management first reported a position in GOSS in Q3 2019 and held it in 6 quarters. The position peaked at $4.23M in Q3 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Caption Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 891 Gossamer Bio shares in Q2 2026, an estimated $23.4K.
  • Caption Management first reported a position in Gossamer Bio in Q3 2019 and held it in 6 quarters.
  • Caption Management's Gossamer Bio position peaked at $4.23M in Q3 2019.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.